These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses? Brodie MJ; Kelly K; Stephen LJ Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766 [TBL] [Abstract][Full Text] [Related]
4. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial. Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628 [TBL] [Abstract][Full Text] [Related]
5. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs. Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839 [TBL] [Abstract][Full Text] [Related]
6. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T; Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227 [TBL] [Abstract][Full Text] [Related]
7. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs. Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629 [TBL] [Abstract][Full Text] [Related]
8. Minimizing pharmacodynamic interactions of high doses of lacosamide. Edwards HB; Cole AG; Griffiths AS; Lin B; Bean A; Krauss GL Acta Neurol Scand; 2012 Apr; 125(4):228-33. PubMed ID: 22070525 [TBL] [Abstract][Full Text] [Related]
9. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs. Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359 [TBL] [Abstract][Full Text] [Related]
12. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754 [TBL] [Abstract][Full Text] [Related]
13. Prospective audit with adjunctive perampanel: Preliminary observations in focal epilepsy. Brodie MJ; Stephen LJ Epilepsy Behav; 2016 Jan; 54():100-3. PubMed ID: 26700063 [TBL] [Abstract][Full Text] [Related]
14. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures. García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484 [TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures. Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895 [TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation. Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854 [TBL] [Abstract][Full Text] [Related]
17. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures. Gidal BE; Ferry J; Majid O; Hussein Z Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853 [TBL] [Abstract][Full Text] [Related]
18. Lacosamide for the treatment of partial-onset seizures. Biton V Expert Rev Neurother; 2012 Jun; 12(6):645-55. PubMed ID: 22650166 [TBL] [Abstract][Full Text] [Related]
19. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide. Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191 [TBL] [Abstract][Full Text] [Related]
20. A prospective audit of adjunctive zonisamide in an everyday clinical setting. Stephen LJ; Kelly K; Wilson EA; Parker P; Brodie MJ Epilepsy Behav; 2010 Apr; 17(4):455-60. PubMed ID: 20207201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]